{"vulnerability": "CVE-2026-52866", "sightings": [{"uuid": "a8de4d54-9185-4d68-a402-708002a1ef9d", "vulnerability_lookup_origin": "1a89b78e-f703-45f3-bb86-59eb712668bd", "author": "86ecb4e1-bb32-44d5-9f39-8a4673af8385", "vulnerability": "CVE-2026-52866", "type": "seen", "source": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01", "content": "", "creation_timestamp": "2026-06-18T05:00:00.000000Z"}, {"uuid": "7f16ba41-2ac3-4e11-9735-22c9bec878b4", "vulnerability_lookup_origin": "1a89b78e-f703-45f3-bb86-59eb712668bd", "author": "9f56dd64-161d-43a6-b9c3-555944290a09", "vulnerability": "CVE-2026-52866", "type": "seen", "source": "https://bsky.app/profile/boredchilada.bsky.social/post/3molmxpdsxc2g", "content": "~Cisa~\nVulnerabilities in Apollo Pharmacy Blood Glucose Monitors allow BLE interception of health data and DoS attacks.\n-\nIOCs: CVE-2026-50034, CVE-2026-52866\n-\n#CVE202650034 #CVE202652866 #ThreatIntel", "creation_timestamp": "2026-06-18T20:07:56.522640Z"}]}